Sep 29, 2026 08:05AM
Sep 28, 2026 08:31AM
Aug 21, 2026 04:23PM
Aug 14, 2026 10:00AM
Aug 4, 2026 09:15AM
Jul 29, 2026 02:18PM
May 18, 2026 04:27PM Silexion Therapeutics (SLXN) Misses Q1 EPS by 85c
May 15, 2026 08:29AM
May 14, 2026 09:27AM
Jan 6, 2026 07:32AM
Jan 6, 2026 07:30AM
Dec 15, 2025 07:55AM
Nov 12, 2025 05:13PM
Sep 30, 2025 08:52AM Silexion reports SIL204 shows up to 99.7% inhibition across KRAS mutations
Sep 26, 2025 04:34PM
Sep 11, 2025 07:02AM
Jul 31, 2025 09:58AM
Jul 16, 2025 08:44AM
Jul 9, 2025 08:35AM
May 29, 2025 09:06AM
May 21, 2025 08:46AM Silexion Therapeutics (SLXN) Completes Key Preclinical Studies Exploring SIL204’s Potential Impact on Colorectal and Lung Cancer
Apr 23, 2025 09:21AM
Mar 28, 2025 08:31AM
Mar 27, 2025 04:19PM
Mar 5, 2025 08:31AM
Jan 28, 2025 08:29AM
Jan 15, 2025 04:02PM
Dec 17, 2024 06:31AM Sielox (SLXN) collaborates with Evonik on advanced siRNA Formulation Development
Oct 1, 2024 06:45AM
Sep 24, 2024 07:34AM
Sep 10, 2024 06:25AM

461,280 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All